John Nicholson
2012
In 2012, John Nicholson earned a total compensation of $1.3M as Senior Vice President and Chief Financial Officer at Nektar Therapeutics, a 11% increase compared to previous year.
Compensation breakdown
| Bonus | $500 |
|---|---|
| Non-Equity Incentive Plan | $357,000 |
| Option Awards | $377,540 |
| Salary | $509,529 |
| Other | $12,225 |
| Total | $1,256,794 |
Nicholson received $509.5K in salary, accounting for 41% of the total pay in 2012.
Nicholson also received $500 in bonus, $357K in non-equity incentive plan, $377.5K in option awards and $12.2K in other compensation.
Rankings
In 2012, John Nicholson's compensation ranked 5,234th out of 11,487 executives tracked by ExecPay. In other words, Nicholson earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,234 out of 11,487 | 54th |
Division Manufacturing | 1,831 out of 4,253 | 57th |
Major group Chemicals And Allied Products | 439 out of 1,198 | 63rd |
Industry group Drugs | 287 out of 920 | 69th |
Industry Pharmaceutical Preparations | 225 out of 700 | 68th |
Source: SEC filing on April 30, 2015.
Nicholson's colleagues
We found four more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2012.